View Older Stories View More Recent Stories

Sep 27, 2024 06:44AM Inventiva SA (IVA) PT Lowered to $14 at H.C. Wainwright
Sep 27, 2024 06:43AM Travere Therapeutics (TVTX) PT Lowered to $18 at H.C. Wainwright
Sep 26, 2024 06:45AM H.C. Wainwright Reiterates Neutral Rating on Durect Corp (DRRX)
Sep 24, 2024 06:51AM H.C. Wainwright Reiterates Neutral Rating on Assembly Biosciences (ASMB)
Sep 23, 2024 06:39AM H.C. Wainwright Reiterates Buy Rating on Genfit (GNFT)
Sep 20, 2024 06:54AM H.C. Wainwright Reiterates Buy Rating on Aligos Therapeutics Inc. (ALGS)
Sep 17, 2024 06:50AM H.C. Wainwright Reiterates Buy Rating on Akero Therapeutics (AKRO)
Sep 13, 2024 06:43AM H.C. Wainwright Reiterates Buy Rating on Pliant Therapeutics (PLRX)
Sep 10, 2024 06:44AM H.C. Wainwright Reiterates Buy Rating on Iterum Therapeutics (ITRM)
Sep 6, 2024 06:55AM H.C. Wainwright Reiterates Buy Rating on Akebia Therapeutics (AKBA)
Sep 6, 2024 06:53AM H.C. Wainwright Reiterates Buy Rating on Aurinia Pharmaceuticals (AUPH)
Sep 6, 2024 06:12AM Travere Therapeutics (TVTX) PT Raised to $23 at H.C. Wainwright
Sep 4, 2024 07:27AM H.C. Wainwright Reiterates Buy Rating on Unicycive Therapeutics (UNCY)
Aug 19, 2024 06:13AM H.C. Wainwright Starts Aligos Therapeutics Inc. (ALGS) at Buy
Aug 16, 2024 06:44AM Unicycive Therapeutics (UNCY) PT Lowered to $2.50 at H.C. Wainwright
Aug 15, 2024 06:42AM Iterum Therapeutics (ITRM) PT Lowered to $5 at H.C. Wainwright
Aug 14, 2024 06:18AM H.C. Wainwright Upgrades Cidara Therapeutics (CDTX) to Buy
Aug 12, 2024 06:13AM Akebia Therapeutics (AKBA) PT Raised to $7.50 at H.C. Wainwright
Aug 7, 2024 06:50AM Arcturus Therapeutics (ARCT) PT Raised to $63 at H.C. Wainwright
Aug 5, 2024 06:57AM Ardelyx, Inc (ARDX) PT Raised to $11 at H.C. Wainwright
Jul 26, 2024 02:51PM Mirum Pharmaceuticals (MIRM) said approached by Sobi about a takeover - source
Jul 19, 2024 09:59AM H.C. Wainwright Reiterates Buy Rating on Ardelyx, Inc (ARDX)
Jul 16, 2024 10:53AM H.C. Wainwright Reiterates Buy Rating on Pliant Therapeutics (PLRX)
Jul 11, 2024 10:32AM H.C. Wainwright Reiterates Buy Rating on Unicycive Therapeutics (UNCY)
Jul 10, 2024 02:03PM H.C. Wainwright Reiterates Buy Rating on Unicycive Therapeutics (UNCY)
Jul 5, 2024 06:34AM Ardelyx, Inc (ARDX) PT Lowered to $10 at H.C. Wainwright
Jul 2, 2024 06:38AM H.C. Wainwright Reiterates Buy Rating on Arcturus Therapeutics (ARCT)
Jul 1, 2024 06:38AM H.C. Wainwright Reiterates Buy Rating on Mirum Pharamceuticals (MIRM)
Jun 18, 2024 06:43AM Mirum Pharamceuticals (MIRM) PT Raised to $66 at H.C. Wainwright
Jun 4, 2024 05:30PM Aurinia Addresses Dubious Proposals Put Forth by Lucien Selce
May 22, 2024 06:13AM H.C. Wainwright Reiterates Neutral Rating on Durect Corp (DRRX)
May 10, 2024 06:57AM 89bio Inc. (ETNB) PT Lowered to $29 at H.C. Wainwright
May 8, 2024 06:51AM Enanta Pharmaceuticals (ENTA) PT Lowered to $27 at H.C. Wainwright
May 7, 2024 07:11AM Pliant Therapeutics (PLRX) PT Lowered to $36 at H.C. Wainwright
Apr 25, 2024 06:40AM Travere Therapeutics (TVTX) PT Raised to $19 at H.C. Wainwright
Apr 1, 2024 11:09AM Akebia Therapeutics (AKBA) PT Raised to $6 at H.C. Wainwright, 'favorable label to daprodustat'
Mar 15, 2024 08:00AM Iterum Therapeutics to Participate in H.C. Wainwright Virtual @Home Fireside Chat
Mar 14, 2024 06:32AM Mirum Pharamceuticals (MIRM) PT Raised to $58 at H.C. Wainwright
Feb 23, 2024 06:08AM Ardelyx, Inc (ARDX) PT Raised to $13 at H.C. Wainwright
Feb 7, 2024 06:07AM H.C. Wainwright Upgrades Iterum Therapeutics (ITRM) to Buy
Nov 8, 2023 06:26AM H.C. Wainwright Downgrades Durect Corp (DRRX) to Neutral, 'AHFIRM disappoints'
Sep 8, 2023 06:06AM H.C. Wainwright Starts ZyVersa Therapeutics, Inc. (ZVSA) at Buy, 'We Uncover Two Diamonds in the Rough'
Sep 7, 2023 06:06AM H.C. Wainwright Starts Ardelyx, Inc (ARDX) at Buy 'Ahead of the potential approval of XPHOZAH next quarter'
Aug 28, 2023 06:08AM H.C. Wainwright Upgrades Akebia Therapeutics (AKBA) to Buy, 'What we have been waiting for'
Jul 13, 2023 06:27AM H.C. Wainwright Double Upgrades Intercept Pharmaceuticals (ICPT) to Buy
May 22, 2023 11:14AM Intercept Pharma (ICPT) cut to sell as FDA advisory committee votes to defer NDA approval
May 22, 2023 06:56AM H.C. Wainwright Downgrades Intercept Pharmaceuticals (ICPT) to Sell
May 15, 2023 08:00AM Galectin Therapeutics Reports Financial Results for the Quarter Ended March 31, 2023 and Provides Business Update
May 11, 2023 06:21AM H.C. Wainwright Upgrades Arcturus Therapeutics (ARCT) to Buy, 'Expecting ARCT-154 Approval in Japan As COVID-19 Vaccine and Booster in 2023'
Apr 27, 2023 08:00AM Galectin Therapeutics to Participate in the H.C. Wainwright BioConnect Investment Conference May 2, 2023
View More Recent Stories View Older Stories